Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $2.03 Million - $2.21 Million
-32,841 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $10,562 - $11,879
178 Added 0.54%
32,841 $2.07 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $25,001 - $28,331
433 Added 1.34%
32,663 $2.03 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $51,629 - $57,212
899 Added 2.87%
32,230 $1.94 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $243,894 - $285,136
-4,449 Reduced 12.43%
31,331 $1.84 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $211,676 - $307,615
4,562 Added 14.61%
35,780 $1.99 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $1.02 Million - $1.33 Million
20,661 Added 195.71%
31,218 $2 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $126,513 - $150,000
2,958 Added 38.93%
10,557 $535,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $17,000 - $18,798
-381 Reduced 4.77%
7,599 $345,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $12,227 - $14,579
271 Added 3.52%
7,980 $381,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $21,649 - $28,074
-444 Reduced 5.45%
7,709 $401,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $22,020 - $24,837
399 Added 5.15%
8,153 $506,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $30,823 - $38,417
-610 Reduced 7.29%
7,754 $429,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $59,920 - $68,980
-1,000 Reduced 10.68%
8,364 $529,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $61,318 - $66,853
1,023 Added 12.26%
9,364 $574,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $25,405 - $29,320
460 Added 5.84%
8,341 $532,000
Q2 2017

Aug 14, 2017

BUY
N/A
7,881
7,881 $439,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Bank & Trust CO Portfolio

Follow Capital Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.